Treatment of Type 2 Diabetes
Lowering blood sugar alone is not enough. We treat according to the National Care Guideline — and look at weight, blood pressure, and sleep along with it.
Type 2 diabetes mellitus is a chronic disease characterized by progressive insulin resistance and beta cell dysfunction. Treatment is based on the National Care Guideline (NVL) Type 2 Diabetes[1] and is adapted to the individual situation — HbA1c targets, comorbidities, age, and functional capacity all play a role. It's not just about blood sugar, but also about preventing heart attacks, strokes, and kidney damage.
What treatment includes
- Metabolic control: Individualized pharmacological therapy with HbA1c targets between 6.5 and 8.0% depending on patient situation
- Weight reduction: Structured program according to S3 guideline (AWMF 050-001)[2] with BIA checks, nutritional counseling, and if needed, GLP-1 therapy
- Cardiovascular risk reduction: Blood pressure control, lipid management, and reduction of thromboembolic events
- Sleep medicine aspects: Screening for obstructive sleep apnea (OSA) as a risk factor for insulin resistance[3] and therapy failure
- Prevention of complications: Early detection and prevention of nephropathy, neuropathy, retinopathy, and cardiovascular disease
The combination of obesity, sleep disorders, and diabetes requires diagnostics that consider these connections. The DiRECT study showed: with structured weight loss of 10–15 kg, 57% of participants achieved diabetes remission.[4] Therefore, isolated blood sugar reduction without considering weight and sleep is often insufficient.
References
- National Care Guideline (NVL) Type 2 Diabetes. German Medical Association (BÄK), Association of Statutory Health Insurance Physicians (KBV), AWMF. Version 3.0, 2023.
- S3 Guideline Obesity — Prevention and Therapy. AWMF Register No. 050-001, German Obesity Society (DAG), updated 2024.
- Reutrakul S, Van Cauter E. Sleep influences on obesity, insulin resistance, and risk of type 2 diabetes. Metabolism. 2018;84:56–66.
- Lean MEJ, Leslie WS, Barnes AC et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391(10120):541–551.
Address
Georg-Schumann-Straße 257
04159 Leipzig
Contact
Phone: 0341 5210871
Email: info@internist-wenzel.de